SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing
4 references·16 citing·21 second hop
Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing (2010)Prevalence, incidence, and residual risk …A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)A new strategy for estimating…Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)Detection of HIV-1 and HCV In…Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Current prevalence and incide…The Risk of Transfusion-Transmitted Viral Infections (1996)The Risk of Transfusion-Trans…HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12‐month deferral policy for men who have sex with men (2021)HIV, HCV, and HBV incidence a…Assessing the global burden of hemorrhage: The global blood supply, deficits, and potential solutions (2021)Assessing the global burden o…Screening Blood Donors for HIV, HCV, and HBV at the American Red Cross: 10-Year Trends in Prevalence, Incidence, and Residual Risk, 2007 to 2016 (2020)Screening Blood Donors for HI…History and Future of Nucleic Acid Amplification Technology Blood Donor Testing (2019)History and Future of Nucleic…Transfusion-Transmitted Infections: an Update on Product Screening, Diagnostic Techniques, and the Path Ahead (2018)Transfusion-Transmitted Infec…Risk factors for retrovirus and hepatitis virus infections in accepted blood donors (2014)Risk factors for retrovirus a…Prevalence of human immunodeficiency virus RNA and antibody in first‐time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios (2013)Prevalence of human immunodef…Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety? (2013)Hepatitis B virus testing by …Comparative analysis of triplex nucleic acid test assays in United States blood donors (2013)Comparative analysis of tripl…Blood safety and availability: continuing challenges in C hina's blood banking system (2013)Blood safety and availability…Multinational assessment of blood‐borne virus testing and transfusion safety on the African continent (2012)Multinational assessment of b…HIV Transmission Through Transfusion—Missouri and Colorado, 2008 (2011)HIV Transmission Through Tran…Donor Testing and Risk: Current Prevalence, Incidence, and Residual Risk of Transfusion-Transmissible Agents in US Allogeneic Donations (2011)Donor Testing and Risk: Curre…Transfusion‐associated infections: 50 years of relentless challenges and remarkable progress (2010)Transfusion‐associated infect…Prevalence, incidence, and residual risk of major blood‐borne infections among apheresis collections to the American Red Cross Blood Services, 2004 through 2008 (2010)Prevalence, incidence, and re…Hepatitis B, hepatitis C and HIV transfusion‐transmitted infections in the 21st century (2010)Hepatitis B, hepatitis C and …Assessing the impact of HBV NAT on window period reduction and residual risk (2006)Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion (2009)International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009 (2011)Emerging infectious disease agents and their potential threat to transfusion safety (2009)Modeling the transmission risk of emerging infectious diseases through blood transfusion (2012)Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk (2017)Pathogen reduction and blood transfusion safety in Africa: strengths, limitations and challenges of implementation in low‐resource settings (2017)Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV‐1 antibody screening (1991)Trends in prevalence, incidence, and residual risk of major transfusion‐transmissible viral infections in United Arab Emirates blood donors: impact of individual‐donation nucleic acid testing, 2004 through 2009 (2012)The prevalence of transfusion-transmitted infections and nucleic acid testing among blood donors in Majmaah, Saudi Arabia (2018)The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection (1997)Prevalence of human immunodeficiency virus , hepatitis B virus, and hepatitis C virus in United States blood donations, 2015 to 2019: The Transfusion‐Transmissible Infections Monitoring System ( TTIMS ) (2020)Civilian walking blood bank emergency preparedness plan (2021)Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018)Prevention of transfusion-transmitted infections (2019)The BLOODSAFE program: Building the future of access to safe blood in Sub‐Saharan Africa (2022)Innovative blood transfusion strategies to address global blood deserts: a consensus statement from the Blood Delivery via Emerging Strategies for Emergency Remote Transfusion (Blood DESERT) Coalition (2024)Mitigating the impact of blood shortages in England (2024)Risk factors for human immunodeficiency virus infection among Brazilian blood donors: a multicentre case–control study using audio computer‐assisted structured interviews (2013)The Use of Rapid Diagnostic Tests for Transfusion Infectious Screening in Africa: A Literature Review (2014)Transfusion-transmitted infections (2007)
this work references cited by second hop

References

  • 1996The Risk of Transfusion-Transmitted Viral Infections1,865 cited
  • 2002Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population642 cited
  • 2004Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing535 cited
  • 2005A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors426 cited

Cited by

  • 2010Transfusion‐associated infections: 50 years of relentless challenges and remarkable progress201 cited
  • 2011Donor Testing and Risk: Current Prevalence, Incidence, and Residual Risk of Transfusion-Transmissible Agents in US Allogeneic Donations198 cited
  • 2010Hepatitis B, hepatitis C and HIV transfusion‐transmitted infections in the 21st century144 cited
  • 2013Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety?109 cited
  • 2020Screening Blood Donors for HIV, HCV, and HBV at the American Red Cross: 10-Year Trends in Prevalence, Incidence, and Residual Risk, 2007 to 201678 cited
  • 2021Assessing the global burden of hemorrhage: The global blood supply, deficits, and potential solutions66 cited
  • 2019History and Future of Nucleic Acid Amplification Technology Blood Donor Testing64 cited
  • 2013Comparative analysis of triplex nucleic acid test assays in United States blood donors62 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

2013
Blood safety and availability: continuing challenges in C hina's blood banking system
61 cited
  • 2012Multinational assessment of blood‐borne virus testing and transfusion safety on the African continent59 cited
  • 2014Risk factors for retrovirus and hepatitis virus infections in accepted blood donors58 cited
  • 2018Transfusion-Transmitted Infections: an Update on Product Screening, Diagnostic Techniques, and the Path Ahead56 cited
  • 2021HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12‐month deferral policy for men who have sex with men52 cited
  • 2013Prevalence of human immunodeficiency virus RNA and antibody in first‐time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios50 cited
  • 2010Prevalence, incidence, and residual risk of major blood‐borne infections among apheresis collections to the American Red Cross Blood Services, 2004 through 200848 cited
  • 2011HIV Transmission Through Transfusion—Missouri and Colorado, 200847 cited